vTv Therapeutics Inc.VTVTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR+10.1%
5Y CAGR+35.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+10.1%/yr
vs -6.6%/yr prior
5Y CAGR
+35.2%/yr
Recent deceleration
Acceleration
+16.7pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$32.80M+30.2%
2024$25.20M-1.2%
2023$25.50M+3.8%
2022$24.56M-4.3%
2021$25.67M+254.0%
2020$7.25M-69.3%
2019$23.66M-26.7%
2018$32.26M-36.7%
2017$50.97M-8.4%
2016$55.65M-